AdaptHealth proyeksikan EBITDA 2026 sebesar $490 juta-$520 juta di tengah pengaturan ulang portofolio dan hambatan kontrak pantai barat (NASDAQ:AHCO)
· seekingalpha.com
Rekapitulasi panggilan laba Q2 2026 AdaptHealth (AHCO): pertumbuhan organik 16%, divestasi segmen Diabetes, pengaturan ulang panduan, risiko kapitasi & pemasok.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...